The clinic will offer evaluation and management of patients with complex cases of C. difficile infection, oral drug therapy, fecal microbiota transplantation, clinical trials for new treatments and ongoing research.
Mayo Clinic gastroenterologists Sahil Khanna, MBBS, and Darrell Pardi, MD, will offer care at the clinic.
More Articles on Gastroenterology:
First Hepatitis C Genotyping Test Earns FDA Approval
Endoscopy Market to be Valued at $10.8B by 2017
Dr. Paul Greenberg Joins Context Matters Board of Advisers
